{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage",
        "Synthetic replication via swap",
        "Counterparty risk",
        "Collateralized swap exposure",
        "Daily leverage reset and compounding effect",
        "High risk rating (7/7)",
        "Opaque payoff structure",
        "Complex underlying index exposure"
    ],
    "classification": "complex",
    "supporting_data": "The product is a 3x leveraged exchange traded product (ETP) seeking to replicate the Solactive Daily Leveraged 3x Long Barclays PLC Index, which provides triple daily exposure to Barclays PLC shares. It is backed by a swap with Natixis as the swap provider, with collateral held in a segregated account. The use of a swap as the core replication method classifies it as synthetic replication, which introduces counterparty and collateral risk. The product employs daily leverage reset, causing a compounding effect that makes returns over periods longer than one day deviate from a simple 3x multiple of the underlying asset's return, adding complexity. The product is explicitly described as high risk (risk class 7/7), with potential for total loss of investment. The intended retail investor is required to have specific knowledge and experience to understand the product and its risks. These features align with MiFID II criteria for complex instruments: use of derivatives integral to the strategy, leverage beyond UCITS limits, synthetic replication, and payoff structures difficult for retail investors to understand. Therefore, it is classified as complex under MiFID II. This is consistent with ESMA and CESR guidance that synthetic ETFs, leveraged products, and those with embedded swaps or derivatives are complex and require appropriateness assessments."
}